tiprankstipranks
Trending News
More News >
Tenax Therapeutics (TENX)
NASDAQ:TENX
US Market

Tenax Therapeutics (TENX) Drug Pipeline

Compare
599 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Tnx-103
Pulmonary Hypertension Associated With Hfpef
Phase III
Recruiting
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Dec 15, 2025
Tnx-103
Pulmonary Hypertension
Phase III
Recruiting
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Aug 01, 2023
Levosimendan 2.5 Mg/Ml Injectable Solution
Heart Failure With Normal Ejection Fraction, Hypertension Pulmonary Secondary Heart Failure, Right Sided Heart Failure With Normal Ejection Fraction
Phase II
Completed
Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients
Jul 24, 2018
Levosimendan
Hypertension Pulmonary Secondary, Heart Failure, Right Sided, Heart Failure With Normal Ejection Fraction
Phase II
Completed
Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF
May 03, 2018

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Tenax Therapeutics (TENX) have in its pipeline
      TENX is currently developing the following drugs: Tnx-103, Tnx-103, Levosimendan 2.5 Mg/Ml Injectable Solution. These drug candidates are in various stages of clinical development as the company works toward FDA approval.